A pre-treatment technique for improving anaerobic digestion hydrolysis, to increase energy output by 20% and achieve 2x throughput
A pre-treatment technique for improving anaerobic digestion hydrolysis, to increase energy output by 20% and achieve 2x throughput
批准号:
133694
负责人:
金额:
$8.76万
依托单位:
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
"Anaerobic digestion (AD) is a well-established, renewable energy solution that plays a role in the supply and security of the UK's energy -- generating biogas fuel (methane & carbon dioxide) from organic waste (agricultural waste, food waste, wastewater etc). There are currently ~17,300 biogas and 460 biomethane AD plants in operation across Europe (European Biogas Association, 2015) -- with 523 of these in operation across the UK (EBA, 2016).However, the first and last stages of anaerobic digestion (hydrolysis and methanogenesis) are severely rate-limiting and result in the current long throughput times of 30 days and low degradation rates of 50-70%. As a result, although the technique has been adopted widely throughout the agricultural and wastewater sectors, its cost-effectiveness is considerably hindered and AD processors often rely heavily on government subsidies in order to remain operational. However government subsidies (green energy subsidies and feed in tariffs) have been reducing dramatically over the past few years, in some cases by as much as 40% (Department of Energy & Climate Change, Jan 2017). Our novel concept will address the poor performance associated with the hydrolysis stage of anaerobic digestion in order to maximise energy output (more energy generated from renewable sources) and improve throughput time of feedstock in order to increase profitability of AD for the benefit of processors and UK society."
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
-
批准号:82371144
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汪雪玲
-
依托单位:
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
-
批准号:82371251
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:肖勤
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
基于仿生矿化法构建氢离子捕获的炎症调节性水凝胶微球在卒中治疗中的研究
-
批准号:82372120
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮慧瞳
-
依托单位:
MICA基因及其抗体在肾移植排斥反应中的作用机制与干预策略研究
-
批准号:30872530
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2008
-
负责人:侯建全
-
依托单位: